Clinical Trial

The Role of Plant-Based Omega-3 Fatty Acids and Molecular Characterisation in Individuals With Cardiovascular(CVD) Risk

Not Yet Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated December 16, 2024 (before its estimated August 30, 2025 completion). Its status may not reflect the trial's current state.
Summary
The goal of this clinical trial is to investigate the outcome of plant-based omega-3 intervention on lipid profile and blood pressure after 12 weeks and to study the molecular markers associated with the incidence of CVD risk. The main questions it aims to answer are: * What is the role of plant-based omega-3 intervention on lipid profile and blood pressure of individuals with CVD risk after 12 weeks? * What is the association between unique molecular markers and plant-based omega-3 intervention among individuals with CVD risk? Participants will be subjected to two groups: * Treatment group: Receive standard dietary therapy and plant-based omega-3 supplemental beverage consumed once daily during breakfast * Control group: Receive only standard dietary therapy Researcher will compare between treatment and control group to see the effect of plant based omega-3 on lipid profile and blood pressure after 12 weeks
Protocol Amendment History 2 amendments
This ClinicalTrials.gov record has been amended 2 times since 2023-05-21; most recent amendment 2024-12-11.
Trial Details
NCT Number NCT05882266
Lead Sponsor Universiti Putra Malaysia
Collaborators: Beacon Hospital Sdn Bhd
Conditions Cardiovascular Risk
Enrollment 72 participants
Start Date 2024-12-20
Primary Completion 2025-08-30 (estimated)
Study Completion 2025-12-30 (estimated)
Updated on ClinicalTrials.gov 2024-12-16